Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis

Gut

Volumn 52, Issue 8, 2003, Pages 1178-1181

  Boige, V ^a,b   Castera L ^b   De Roux, N ^b   Ganne Carrie N ^c   Ducot, B ^d   Pelletier, G ^b   Beaugrand, M ^c   Buffet, C ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BICÊTRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HFE PROTEIN; IRON;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEREDITY; HETEROZYGOTE; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTRICTION MAPPING;

CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; RISK FACTORS;

EID: 0037961144     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.8.1178     Document Type: Article

References (28)

1. Ganne-Carrie N, Chostang C, Chapel F, et al. Predictive score of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23:1112-8.
2. Cottone M, Turri M, Caltagirone M, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafoetoprotein. J Hepatol 1994;21:1029-34.
3. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
4. Kew MD. Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: occurrence in non-cirrhotic patients. Hepatology 1990;11:1086-7.
5. Britto MR, Thomas LA, Balaratnam N, et al. Hepatocellular carcinoma in non-cirrhotic liver in genetic haemochromatosis. Scand J Gastroenterol 2000;35:889-93.
6. Bradbear R, Bain C, Siskind V, et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic non-alcoholic liver disease. J Natl Cancer Inst 1985;75:81-4.
7. Fargion S, Mandelli C, Piperno A, et al. Survival and prognosis factors in 212 italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9.
8. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
9. Bralet MP, Degott C, Belghiti J, et al. Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma. J Hepatol 1998;28:740-1.
10. Blanc JF, De Ledinghen V, Trimoulet P, et al. Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation. J Hepatol 1999;30:325-9.
11. Blanc JF, De Ledinghen V, Bernard PH, et al. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol 2000;32:805-11.
12. Gochee PA, Powell LW, Cullen DJ, et al. A population-based study of the biochemical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-51.
13. Powell L, Summers K, Board P, et al. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 1990;98:1625-32.
14. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-61.
15. Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:251-2.
16. Willis G, Wimperis JZ, Lonsdale R, et al. Haemochromatosis gene mutation in hepatocellular cancer. Lancet 1997;350:565-6.
17. Lauret E, Rodriguez M, Gonzalez S, et al. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol 2002;9:1016-21.
18. Aldersley MA, Komolmit P, Hamlin PJ, et al. Increased prevalence of the hemochromatosis gene mutations in patients with hepatocellular carcinoma. Gastroenterology 1999:116:A1182.
19. Cauza E, Ulrich-Pur H, Peck-Radosavjevic M, et al. HFE mutations in patients with hepatocellular carcinoma. Gastroenterology 1999;116:A1195.
20. Kazemi-Shiraki L, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-34.
21. Moirand R, Jouanolle AM, Brissot P, et al. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 1999;116:372-7.
22. Piperno A, Vergani A, Malosio I, et al. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology 1998;28:1105-9.
23. Thoburn D, Curry G, Spooner R, et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002:50:248-52.
24. Grove J, Daly AK, Burt AD, et al. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 1998;43:262-6.
25. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997;112:882-8.
26. Cotler SJ, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998;29:257-62.
27. Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developped on a non-cirrhotic liver. Hepatology 1995;22:446-50.
28. Ganne-Carrié N, Christidis C, Chastang C, et al. Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Gut 2000;46:277-82.